A network of hypertension-related genes is proposed based on biological pathways.
Statistical and topological characteristics of the gene network are analyzed.
Seven key hub genes of hypertension are determined through integrated centrality.
The modular structure analysis can facilitate the exploration of drug targets.
The network approach provides another perspective to explore disease pathogenesis.